However, the pathogenesis of osteoporosis involves multiple signalling pathways, and a recent network pharmacological and molecular analysis preliminarily verified that angelicin could exert anti-osteoporosis effects through the PI3K/AKT/mTOR pathway [44]. The gene discussed is AKT1; the disease is osteoporosis.